GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...
Clovis Oncology, Pfizer, and GlaxoSmithKline have also marketed rival PARP drugs, with the latter two making significant acquisitions – Medivation and Tesaro, respectively – to add the ...
A Bex and T Powles have been involved in the advisory boards of Pfizer, GlaxoSmithKline, Novartis and Bayer. The authors have no other relevant affiliations or financial involvement with any ...
Pfizer, GlaxoSmithKline Intellectual Property Development, Sanofi US Services, Maze Therapeutics, Janssen Biotech, Novartis AG and Boehringer Ingelheim International GmbH. Competing interests None ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback